Novo Nordisk A/S’s sales of blockbuster weight-loss drug Wegovy beat expectations in the third quarter, a potential relief ...

Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations, said that its net profit in the ...

COPENHAGEN (Reuters) -Weight-loss and diabetes drugmaker Novo Nordisk on Wednesday posted third-quarter operating profit in ...

Weight-loss and diabetes drugmaker Novo Nordisk on Wednesday posted third-quarter operating profit in line with expectations ...

Novo Nordisk narrowed its full-year guidance after its blockbuster Wegovy weight-loss drug beat sales expectations.Soaring ...

According to a recent study by Future Market Insights, the global anorexiant market is on a robust growth trajectory, with an anticipated compound annual growth rate (CAGR) of 5.1% over the forecast ...